EBITDA Margin % is calculated as EBITDA divided by its Revenue. NeueHealth's EBITDA for the
three
months ended in Jun. 2025 was $17.3 Mil. NeueHealth's Revenue for the
three
months ended in Jun. 2025 was $209.1 Mil. Therefore, NeueHealth's EBITDA margin for the quarter that ended in Jun. 2025 was 8.25%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
NeueHealth EBITDA Margin % Related Terms
NeueHealth EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for NeueHealth's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NEUE vs PFHO, UNH, CVS: EBITDA Margin % Comparison
For the Healthcare Plans subindustry, NeueHealth's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NeueHealth EBITDA Margin % vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, NeueHealth's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where NeueHealth's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NeueHealth (NEUE) has a EBITDA Margin % of 8.25% as of Jun. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on NeueHealth and its competitors.
Is NeueHealth's EBITDA Margin % too high?
NeueHealth's current EBITDA Margin % is 8.25%. The Healthcare Plans industry median EBITDA Margin % is 4.56. NeueHealth's value of 8.25% is 81.1% above this industry median. Overall, NeueHealth has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does NeueHealth's EBITDA Margin % compare to PFHO and UNH?
NeueHealth's EBITDA Margin % of 8.25% can be compared against companies in the Healthcare Plans industry. The industry median EBITDA Margin % is 4.56. NeueHealth's value of 8.25% is 81.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Plans company?
The median EBITDA Margin % among Healthcare Plans companies is 4.56, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NeueHealth's current EBITDA Margin % of 8.25% is 81.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on NeueHealth and its competitors. For the Healthcare Plans industry, the median EBITDA Margin % is 4.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NeueHealth's current EBITDA Margin % is 8.25%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeueHealth stock overvalued right now?
NeueHealth (NEUE) has a current EBITDA Margin % of 8.25%. The stock's GF Value™ is $8.81, compared to a current price of $6.75 — trading 23.3% below its estimated fair value. The current EBITDA Margin % is 8.25% and 81.1% above the Healthcare Plans industry median of 4.56. NeueHealth's overall GF Score™ is 20/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For NeueHealth (NEUE), the current EBITDA Margin % is 8.25% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NeueHealth (NEUE) Overvalued in 2026?
Based on GuruFocus' analysis, NeueHealth stock appears to be undervalued.
The current stock price of $6.75 is trading 23.3% below its estimated GF Value™ of $8.81.
Key valuation signals for NEUE:
EBITDA Margin %: 8.25%
GF Value™: $8.81 vs. price of $6.75 (23.3% below fair value)
Industry Position: 81.1% above the Healthcare Plans median
No single metric tells the full story. See the NEUE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.
20GF Score
Get the complete analysis for NEUE
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NEUE has been successfully added to your 
